AIM:EKF

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

EKF Diagnostics Holdings

Executive Summary

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, and Africa. More Details


Snowflake Analysis

Flawless balance sheet with questionable track record.


Similar Companies

Share Price & News

How has EKF Diagnostics Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: EKF is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: EKF's weekly volatility (8%) has been stable over the past year.


Market Performance


7 Day Return

-3.1%

EKF

-1.0%

GB Medical Equipment

1.2%

GB Market


1 Year Return

95.3%

EKF

-7.4%

GB Medical Equipment

-9.6%

GB Market

Return vs Industry: EKF exceeded the UK Medical Equipment industry which returned -7.5% over the past year.

Return vs Market: EKF exceeded the UK Market which returned -9.1% over the past year.


Shareholder returns

EKFIndustryMarket
7 Day-3.1%-1.0%1.2%
30 Day-5.3%2.2%8.6%
90 Day7.8%-0.9%5.4%
1 Year98.0%95.3%-5.6%-7.4%-6.1%-9.6%
3 Year192.7%136.2%17.4%10.6%-0.6%-12.6%
5 Year540.4%416.7%38.3%27.1%23.3%-4.4%

Long-Term Price Volatility Vs. Market

How volatile is EKF Diagnostics Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is EKF Diagnostics Holdings undervalued compared to its fair value and its price relative to the market?

44.25x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: EKF (£0.64) is trading above our estimate of fair value (£0.44)

Significantly Below Fair Value: EKF is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: EKF is poor value based on its PE Ratio (45.7x) compared to the GB Medical Equipment industry average (36.2x).

PE vs Market: EKF is poor value based on its PE Ratio (45.7x) compared to the UK market (20.1x).


Price to Earnings Growth Ratio

PEG Ratio: EKF's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: EKF's PB Ratio (3.7x) is in line with the GB Medical Equipment industry average.


Next Steps

Future Growth

How is EKF Diagnostics Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

-23.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EKF's earnings are forecast to decline over the next 3 years (-23.3% per year).

Earnings vs Market: EKF's earnings are forecast to decline over the next 3 years (-23.3% per year).

High Growth Earnings: EKF's earnings are forecast to decline over the next 3 years.

Revenue vs Market: EKF's revenue is expected to decline over the next 3 years (-8.3% per year).

High Growth Revenue: EKF's revenue is forecast to decline over the next 3 years (-8.3% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EKF's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has EKF Diagnostics Holdings performed over the past 5 years?

60.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EKF has high quality earnings.

Growing Profit Margin: EKF's current net profit margins (12.8%) are lower than last year (24.6%).


Past Earnings Growth Analysis

Earnings Trend: EKF has become profitable over the past 5 years, growing earnings by 60.8% per year.

Accelerating Growth: EKF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: EKF had negative earnings growth (-40.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (-14.4%).


Return on Equity

High ROE: EKF's Return on Equity (8.4%) is considered low.


Next Steps

Financial Health

How is EKF Diagnostics Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: EKF's short term assets (£35.6M) exceed its short term liabilities (£20.4M).

Long Term Liabilities: EKF's short term assets (£35.6M) exceed its long term liabilities (£4.1M).


Debt to Equity History and Analysis

Debt Level: EKF's debt to equity ratio (0.8%) is considered satisfactory.

Reducing Debt: EKF's debt to equity ratio has reduced from 7.5% to 0.8% over the past 5 years.

Debt Coverage: EKF's debt is well covered by operating cash flow (1243.4%).

Interest Coverage: EKF's interest payments on its debt are well covered by EBIT (433.9x coverage).


Balance Sheet


Next Steps

Dividend

What is EKF Diagnostics Holdings's current dividend yield, its reliability and sustainability?

1.61%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: EKF's dividend (1.56%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.72%).

High Dividend: EKF's dividend (1.56%) is low compared to the top 25% of dividend payers in the UK market (4.91%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether EKF's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if EKF's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (71.4%), EKF's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: EKF's dividends in 3 years are forecast to be covered by earnings (57.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.6yrs

Average board tenure


CEO

Julian Baines (55 yo)

no data

Tenure

UK£1,637,000

Compensation

Mr. Julian Huw Baines, MBE, serves as a Director of Quotient Diagnostics Limited. Mr. Baines served as a Non-Executive Chairman of Renalytix AI plc since March 15, 2018 until July 16, 2020. Since 2009, he ...


CEO Compensation Analysis

Compensation vs Market: Julian's total compensation ($USD2.18M) is above average for companies of similar size in the UK market ($USD871.97K).

Compensation vs Earnings: Julian's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Board Members

NamePositionTenureCompensationOwnership
Julian Baines
CEO & Executive Directorno dataUK£1.64m0.41%
£ 1.2m
Richard Evans
COO, Finance Director & Executive Directorno dataUK£1.60m0.039%
£ 110.9k
Christopher Mills
Non-Executive Chairman4.58yrsUK£50.00k0.033%
£ 93.0k
Carl Contadini
Independent Non-Executive Director4.33yrsUK£50.00kno data
Adam Reynolds
Senior Independent Directorno dataUK£50.00k0.37%
£ 1.0m

4.6yrs

Average Tenure

63yo

Average Age

Experienced Board: EKF's board of directors are considered experienced (4.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

EKF Diagnostics Holdings plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: EKF Diagnostics Holdings plc
  • Ticker: EKF
  • Exchange: AIM
  • Founded: 1990
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: UK£282.096m
  • Shares outstanding: 454.99m
  • Website: https://www.ekfdiagnostics.com

Number of Employees


Location

  • EKF Diagnostics Holdings plc
  • Avon House
  • 19 Stanwell Road
  • Cardiff
  • South Glamorgan
  • CF64 2EZ
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EKFAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPJun 2002
EKDH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJun 2002

Biography

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, and Africa. It offers ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/23 21:52
End of Day Share Price2020/11/23 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.